11-101-9409

Leflunomide Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Manufacturer: MilliporeSigma Supelco

CAS Number: 75706-12-6

Select a Size

Pack Size SKU Availability Price
Each of 1 11-101-9409-Each-of-1 In Stock ₹ 32,841.00

11-101-9409 - Each of 1

₹ 32,841.00

In Stock

Quantity

1

Base Price: ₹ 32,841.00

GST (18%): ₹ 5,911.38

Total Price: ₹ 38,752.38

CAS

75706-12-6

Type

Certified Reference Material

Linear Formula

C12H9F3N2O2

Synonym

Leflunomide; 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide

Grade

Certified Reference Material

Quantity

1 g

Purity Grade Notes

These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.

MDL Number

MFCD00867593

Formula Weight

270.21

Physical Form

Neat

Other Options

Image Product Name Manufacturer Price Range
50-200-9198
Enzo Life Sciences Leflunomide (50mg). CAS: 75706-12-6
Enzo Life Sciences ₹ 6,857.45
50-175-7919
Sigma Aldrich Fine Chemicals Biosciences Leflunomide Immunosuppressant | 75706-12-6 | MFCD00867593 | 25MG
Sigma Aldrich Fine Chemicals Biosciences ₹ 12,428.85
50-175-7918
Sigma Aldrich Fine Chemicals Biosciences Leflunomide Immunosuppressant | 75706-12-6 | MFCD00867593 | 100MG
Sigma Aldrich Fine Chemicals Biosciences ₹ 39,467.05
PHR1378
Leflunomide
Supelco ₹ 28,480.58
1356960
Leflunomide
Sigma Aldrich ₹ 50,228.00
Y0000674
Leflunomide for peak identification
Sigma Aldrich ₹ 14,267.35
Y0000654
Leflunomide
Sigma Aldrich ₹ 14,267.35
AC57489
75706-12-6 | Leflunomide
A2B Chem ₹ 1,246.00 - ₹ 27,679.00

Related Products

Img

MilliporeSigma Supelco

11-101-4583

--

Img

MilliporeSigma Supelco

11-101-9568

--

Img

MilliporeSigma Supelco

11-101-2786

--

Img

MilliporeSigma Supelco

11-101-9312

--

Img

MilliporeSigma Supelco

11-101-4864

--

Img

MilliporeSigma Supelco

11-101-4829

--

Img

MilliporeSigma Supelco

11-101-9569

--

Img

MilliporeSigma Supelco

11-101-3014

--

Description

  • Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
  • Leflunomide belongs to the new class of immunomodulating drugs with inflammatory and immunomodulating properties
  • It has been investigated for application in transplantation procedures
  • It is also an anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA)
  • Its mode of action involves the inhibition of T-cell proliferation after converting to its active metabolite i.e
  • A771726 in humans.

SAFETY INFORMATION

  • Recommended Storage : 2°C to 8°C